Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes
- 1 February 2005
- journal article
- review article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 3 (2), 254-267
- https://doi.org/10.1111/j.1538-7836.2004.01085.x
Abstract
Atherosclerosis is a multifactorial disease for which the molecular etiology of many of the risk factors is still unknown. As no single genetic marker or test accurately predicts cardiovascular death, phenotyping for markers of inflammation may identify the individuals at risk for vascular diseases. Reactive oxygen species (ROS) are key mediators of signaling pathways that underlie vascular inflammation in atherogenesis, starting from the initiation of fatty streak development through lesion progression to ultimate plaque rupture. Various animal models of atherosclerosis support the notion that ROS released from NAD(P)H oxidases, xanthine oxidase, lipoxygenases, and enhanced ROS production from dysfunctional mitochondrial respiratory chain indeed have a causatory role in atherosclerosis and other vascular diseases. Human investigations also support the oxidative stress hypothesis of atherogenesis. This is further supported by the observed impairment of vascular function and enhanced atherogenesis in animal models that have deficiencies in antioxidant enzymes. The importance of oxidative stress in atherosclerosis is further emphasized because of its role as a unifying mechanism across many vascular diseases. The main contraindicator for the role oxidative stress plays in atherosclerosis is the lack of effectiveness of antioxidants in reducing primary endpoints of cardiovascular death and morbidity. However, this lack of effectiveness by itself does not negate the existence or causatory role of oxidative stress in vascular disease. Lack of proven markers of oxidative stress, which could help to identify a subset of population that can benefit from antioxidant supplementation, and the complexity and subcellular localization of redox reactions, are among the factors responsible for the mixed outcomes in the use of antioxidants for the prevention of cardiovascular diseases. To better understand the role of oxidative stress in vascular diseases, future studies should be aimed at using advances in mouse and human genetics to define oxidative stress phenotypes and link phenotype with genotype.Keywords
This publication has 119 references indexed in Scilit:
- Arterial thrombosis for the interventional cardiologist: From adhesion molecules and coagulation factors to clinical therapeuticsCatheterization and Cardiovascular Interventions, 2003
- Chronic Iron Administration Increases Vascular Oxidative Stress and Accelerates Arterial ThrombosisCirculation, 2003
- Role of oxidative stress in atherosclerosisThe American Journal of Cardiology, 2003
- Enhanced TNFα and oxidative stress in patients with heart failure: effect of TNFα on platelet O2 - productionThrombosis and Haemostasis, 2003
- Differential effects of α- and γ-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesisJournal of the American College of Cardiology, 1999
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.JCI Insight, 1996
- Platelet-Mediated Lymphocyte Delivery to High Endothelial VenulesScience, 1996
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Role of the extracellular matrix in age-related modifications of the rat aorta. Ultrastructural, morphometric, and enzymatic evaluations.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Assessment of chlorination by human neutrophilsNature, 1983